Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
LowReport
Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
Oculis Holding AG (NASDAQ: OCS) had its price target raised by analysts at Robert W. Baird from $37.00 to $41.00. They now have an "outperform" rating on the stock.
LowReport
Oculis Holding AG (NASDAQ: OCS) had its price target raised by analysts at Robert W. Baird from $37.00 to $41.00. They now have an "outperform" rating on the stock.
Oculis Holding AG (NASDAQ: OCS) had its price target lowered by analysts at HC Wainwright from $30.00 to $29.00. They now have a "buy" rating on the stock.
LowReport
Oculis Holding AG (NASDAQ: OCS) had its price target lowered by analysts at HC Wainwright from $30.00 to $29.00. They now have a "buy" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: